Skip to main content

A Cost Analysis of Colonoscopy using Microcosting and Time-and-motion Techniques

Abstract

Background

The cost of an individual colonoscopy is an important determinant of the overall cost and cost-effectiveness of colorectal cancer screening. Published cost estimates vary widely and typically report institutional costs derived from gross-costing methods.

Objective

Perform a cost analysis of colonoscopy using micro-costing and time-and-motion techniques to determine the total societal cost of colonoscopy, which includes direct health care costs as well as direct non-health care costs and costs related to patients’ time. The design is prospective cohort. The participants were 276 contacted, eligible patients who underwent colonoscopy between July 2001 and June 2002, at either a Veterans’ Affairs Medical Center or a University Hospital in the Southeastern United States.

Major results

The median direct health care cost for colonoscopy was $379 (25%, 75%; $343, $433). The median direct non-health care and patient time costs were $226 (25%, 75%; $187, $323) and $274 (25%, 75%; $186, $368), respectively. The median total societal cost of colonoscopy was $923 (25%, 75%; $805, $1047). The median direct health care, direct non-health care, patient time costs, and total costs at the VA were $391, $288, $274, and $958, respectively; analogous costs at the University Hospital were $376, $189, $368, and $905, respectively.

Conclusion

Microcosting techniques and time-and-motion studies can produce accurate, detailed cost estimates for complex medical interventions. Cost estimates that inform health policy decisions or cost-effectiveness analyses should use total costs from the societal perspective. Societal cost estimates, which include patient and caregiver time costs, may affect colonoscopy screening rates.

This is a preview of subscription content, access via your institution.

Figure 1
Figure 2

References

  1. Winawer S, Fletcher RH, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterol. 2003;124:544–60.

    Article  Google Scholar 

  2. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society Guidelines for the Early Detection of Cancer, 2006. Ca Cancer J Clin. 2006;56:11–25.

    PubMed  Article  Google Scholar 

  3. Ladabaum U, Song K. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Gastroenterol. 2005;129:1151–62.

    Article  Google Scholar 

  4. Whynes DK, Neilson AR, Walker AR, Hardcastle JD. Fecal occult blood screening for colorectal cancer: is it cost-effective? Health Econ. 1998;7:21–9.

    PubMed  Article  CAS  Google Scholar 

  5. Ness RM, Holmes AM, Klein R, Dittus R. Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages. Am J Gastroenterol. 2000;95:1800–11.

    PubMed  Article  CAS  Google Scholar 

  6. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA. 2000;284:1954–61.

    PubMed  Article  CAS  Google Scholar 

  7. Loeve F, Brown ML, Boer R, van Ballegooijen M, van Oortmarssen GJ, Habbema JD. Endoscopic colorectal cancer screening: a cost-saving analysis. J Natl Cancer Inst. 2000;92:557–63.

    PubMed  Article  CAS  Google Scholar 

  8. Ladabaum U, Phillips KA. Colorectal Cancer Screening: differential costs for younger versus older Americans. Am J Prev Med. 2006;30:378–84.

    PubMed  Article  Google Scholar 

  9. Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastroenterol. 1995;109:1781–90.

    Article  CAS  Google Scholar 

  10. Bhattacharya I, Sack EM. Screening colonoscopy: the cost of common sense. Lancet. 1996;347:1744–5.

    PubMed  Article  CAS  Google Scholar 

  11. Wagner JL, Herdman RC, Wadhwa S. Cost-effectiveness of colorectal cancer screening in the elderly. Ann Intern Med. 1991;115:807–17.

    PubMed  CAS  Google Scholar 

  12. Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med. 2000;133:573–84.

    PubMed  CAS  Google Scholar 

  13. Sonnenberg A, Delco F. Cost-effectiveness of a single colonoscopy in screening for colorectal cancer. Arch Intern Med. 2002;162:163–8.

    PubMed  Article  Google Scholar 

  14. Luce BR, Manning WG, Siegel JE, Lipscomb J. Estimating costs in cost-effectiveness analysis. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996:176–213.

    Google Scholar 

  15. Whynes DK, Frew EJ, Edwards R, Atkin WS. Costs of flexible sigmoidoscopy screening for colorectal cancer in the United Kingdom. Int J Technol Assess Health Care. 2003;19:384–95.

    PubMed  Article  Google Scholar 

  16. Lewis JD, Asch DA. Barriers to office-based screening sigmoidoscopy: does reimbursement cover costs. Ann Intern Med. 1999;130:525–30.

    PubMed  CAS  Google Scholar 

  17. Stiles RA, Mick SS. Components of the costs of controlling quality: a transaction cost economics approach. Hosp Health Serv Adm. 1997;42:205–12.

    PubMed  CAS  Google Scholar 

  18. US Department of Labor, Bureau of Labor Statistics. National compensation survey: occupational wages in the east south central census division, 2000. Bulletin 2547-6. November, 2001. Available at: http://www.bls.gov/ncs/ocs/sp/ncbl0394.pdf. Accessed August 23, 2006.

  19. Internal Revenue Service, Form 2106. 2001. Available at: http://www.irs.gov/pub/irs-prior/f2106--2001.pdf#search=%22form%202106%202001%22. Accessed August 23, 2006.

  20. Centers for Medicare and Medicaid Services. Changes to the hospital outpatient prospective payment system for calendar year 2002. Regulation No. CMS-1159-F2. Available at: http://www.cms.hhs.gov/HospitalOutpatientPPS/HORD/itemdetail.asp?filterType=dual,%20keyword&filterValue=2002&filterByDID=0&sortByDID=3&sortOrder=descending&itemID=CMS048533&intNumPerPage=10. Accessed March 28, 2007.

  21. Levin B, Smith RA, Feldman GE, et al. Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action. Cancer. 2002;95:1618–28.

    PubMed  Article  Google Scholar 

  22. Maciosek MV, Solberg LI, Coffield AB, Edwards NM, Goodman MJ. Colorectal cancer screening: health impact and cost-effectiveness. Am J Prev Med. 2006;31:80–9.

    PubMed  Article  Google Scholar 

  23. O’Leary BA, Olynyk JK, Neville AM, Platell CF. Cost-effectiveness of colorectal cancer screening: comparison of community based-flexible sigmoidoscopy with fecal occult blood testing and colonoscopy. J Gastroenterol Hepatol. 2004;19:38–47.

    PubMed  Article  Google Scholar 

  24. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness of colorectal cancer screening: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2002;137:96–104.

    PubMed  Google Scholar 

Download references

Acknowledgement

The study was primarily funded through a Discovery grant from the Vanderbilt Ingram Cancer Center. Drs. Ness and Dittus are supported in part by the Tennessee Valley Healthcare System Geriatric Research, Education and Clinical Center and the Vanderbilt Center for Health Services Research. We greatly appreciate the assistance provided by Dr. Ted Speroff, Ms. Amber Norton, and Ms. Patricia Harrison in the completion of this manuscript. Portions of this manuscript were presented at the annual meeting of the Society of General Internal Medicine (May 2003) in Vancouver, Canada.

Conflicts of Interest

None disclosed.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Stephen G. Henry MD.

Appendix

Appendix

Additional details of Microcosting and Time-and-Motion Techniques

Resource Identification

Resources consumed during each transaction included all personnel, equipment, and medications associated with performing colonoscopy as well as resources administered outside the endoscopy unit such as overhead (e.g. utilities), building costs, and administrative costs. Resources consumed during particular transactions were measured through real-time observation. The cost of complications associated with colonoscopy was not addressed in this study.

Direct Observation of Resource Utilization

The same nurse physically accompanied every participant during his or her colonoscopy from the patient’s leaving the waiting room through his or her postprocedure recovery. Using a watch, this nurse recorded the time that all health care personnel arrived at and left a patient’s bedside on a standardized data collection tool that allowed calculation of the total number of minutes that each type of health care personnel (e.g. nurse, resident) spent providing care to each patient. The nurse also directly observed and recorded the medication and equipment used for each procedure.

Using a watch, one author (SGH) personally observed a convenience sample of at least 20 instances of each coordinating transaction at both hospitals and recorded the start and stop times for each coordinating transaction on a standardized data collection instrument that allowed calculation of the mean duration of each coordinating transaction to the nearest minute. For transactions performed by several different types of health care personnel (e.g. nurses and GI technicians), separate sets of observations were made for each personnel type. The mean time required to verify insurance approval at the University Hospital was derived from both observation and interviews with insurance coordinators, who obtained approvals for multiple patients’ procedures in batches rather than processing each patient’s approval separately.

Monetary Valuation of Resources

To estimate operating utilization, we divided the estimated number of hours spent performing procedures during FY 2002 by the total number of room-hours (number of rooms per procedure unit multiplied by the total hours of operation during FY 2002) at each hospital during FY 2002. One author (SGH) observed a convenience sample of at least 20 of each type of noncolonoscopy endoscopic procedure performed at each hospital to determine mean procedure length. These values and the mean duration for colonoscopy at each site were used to calculate the total number of hours spent performing procedures in FY 2002. The capacity utilization was calculated to be 59% for the University Hospital and 48% for the VA Medical Center. After adjusting the per-minute wages for administrative overhead and capacity utilization (see Table 1 notes), labor costs were calculated by multiplying the employee time for each procedure by the appropriate per-minute rate. For transactions that were conducted by more than one type of health care worker, the per-minute compensation rate used to determine cost was a weighted average based on the fraction of total observed transactions completed by each type of health care worker.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Henry, S.G., Ness, R.M., Stiles, R.A. et al. A Cost Analysis of Colonoscopy using Microcosting and Time-and-motion Techniques. J GEN INTERN MED 22, 1415–1421 (2007). https://doi.org/10.1007/s11606-007-0281-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-007-0281-6

KEY WORDS

  • cost analysis
  • colonoscopy
  • colorectal cancer
  • microcosting
  • time-and-motion